NCCN issues first pediatric acute lymphoblastic leukemia guidelines, including use of Voraxaze®

By In The News
July 11, 2019 in The Headlines

Recommended Posts

In The News

Posted July 11, 2019

- Share

Posted July 11, 2019

PHILADELPHIA, July 11, 2019 /PRNewswire/ -- BTG plc (LSE: BTG), the global healthcare company, today highlighted the first publication of National Comprehensive Cancer Network (NCCN) pediatric acute lymphoblastic leukemia (ALL) guidelines including consideration of Voraxaze®...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  220066
2. Jaydee
  16871
3. Kip Powick
  12237
4. deicer
  12233
5. dagger
  9596
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  270.4k
- Total Posts
  
  559.2k

Sign In

NCCN issues first pediatric acute lymphoblastic leukemia guidelines, including use of Voraxaze®

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support